Biomechanical Properties and Their Association With Balance and Functional Mobility in Children With Cerebral Palsy
1 other identifier
observational
80
1 country
1
Brief Summary
This study aimed to investigate the differences in the biomechanical properties of the dorsal trunk and lower extremity muscles of children with unilateral spastic cerebral palsy compared with their typically developing peers, and the effect of these biomechanical properties on balance and functional mobility performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2023
CompletedFirst Submitted
Initial submission to the registry
April 6, 2023
CompletedFirst Posted
Study publicly available on registry
April 19, 2023
CompletedApril 19, 2023
April 1, 2023
5 months
April 6, 2023
April 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
The Pediatric Balance Scale
The Pediatric Balance Scale assesses functional balance in three categories: self-care, mobility and social function, using 14 items. Each item is scored from 0 (indicating low function) to 4 (indicating highest function), with a maximum score of 56 points. A higher score indicates better balance.
Baseline
Trunk Control Measurement Scale
The TCSM was used to assess seated trunk balance and consisted of 15 items. Each item was scored from 0 to 3, with 0 indicating inability to perform the task and 3 indicating the full performance of the item. A high score indicated good trunk control
Baseline
2-Minute Walk Test
The children were asked to walk at a normal pace, without running, and the distance they walked for 2 minutes was recorded.
Baseline
Timed Up and Go Test
The children were seated with their feet in full contact with the floor, in a chair with back support only, and with their hip and knee joints at 90 degrees. On the start command, they were asked to walk 3 metres to the wall at a pace they felt comfortable with and then sit back down in the chair.
Baseline
Muscle tone (Hz)
The muscle tone which is a biomechanical property of the muscles evaluated with a portable hand-held myotonometer. This myotonometer (MyotonPRO - Tallinn, Estonia) is non-invasive and provides a quantitative assessment of a muscle's biomechanical properties. The MyotonPRO applies a short-intensity mechanical impulse on the skin overlying the muscle or facia. The tissue's response then generates a signal that is recorded, and an internal software program produces an acceleration graph.
Baseline
Stiffness (N/m)
The stiffness which is a biomechanical property of muscles will be evaluated with a portable hand-held myotonometer. This myotonometer (MyotonPRO - Tallinn, Estonia) is non-invasive and provides a quantitative assessment of a muscle's biomechanical properties. The MyotonPRO applies a short-intensity mechanical impulse on the skin overlying the muscle or facia. The tissue's response then generates a signal that is recorded, and an internal software program produces an acceleration graph.
Baseline
Study Arms (2)
UCP
Children diagnosed with unilateral spastic cerebral palsy
TyD
Typically developing children
Eligibility Criteria
Children diagnosed with unilateral spastic cerebral palsy (GMFCS level I-II, spasticity level MAS ≤ 2) and their age-matched typically developing peers.
You may qualify if:
- aged between 4 and 12 years,
- spasticity level MAS≤2,
- mental level sufficient to understand commands given,
- and ambulation without the use of an orthosis or other device. In addition, children had to be GMFCS level I or II.
You may not qualify if:
- a history of spinal surgery or spinal orthosis use,
- uncorrected vision or hearing problems,
- severe epileptic seizures,
- lower extremity contractures,
- botulinum toxin A injection in the previous six months,
- lower extremity surgery in less than one year,
- use of pharmacological agents that affect muscle tone,
- and poor cooperation.
- aged between 4 and 12 years,
- no neurological or orthopaedic diagnosis,
- no known systemic problems,
- normal vision and hearing,
- and a mental level sufficient to understand the commands given.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ilke KARAlead
Study Sites (1)
Istanbul Okan University
Istanbul, 34959, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Co-Investigator
Study Record Dates
First Submitted
April 6, 2023
First Posted
April 19, 2023
Study Start
July 1, 2022
Primary Completion
November 20, 2022
Study Completion
February 20, 2023
Last Updated
April 19, 2023
Record last verified: 2023-04